Skip Ribbon Commands
Skip to main content

My child has

Because childhood should be simple ...

Don P. Wilson, M.D.
Cook Children's Physician Network

Don P. Wilson
Specialties:Endocrinology
Education:University of Mississippi
Residency:Baylor Affiliated Hospitals
Fellowship:Baylor Affiliated Hospitals
Board Certified:American Board of Pediatrics and Pediatric Endocrinology

Best doctor in America

A native of Newton, Mississippi, Dr. Don P. Wilson attended the University of Southern Mississippi, receiving a degree in pre-medical education. He earned a medical degree from the University of Mississippi before completing pediatric residency training and post-graduate fellowship in pediatric endocrinology at Baylor College of Medicine in Houston, Texas. He is board certified in pediatrics, pediatric endocrinology and clinical lipidology.

In 1997, Dr. Wilson was selected as Chairman of the Department of Pediatrics, Texas A&M University College of Medicine, a position he held for 12 years. In addition to overseeing an active research and medical education program, Dr. Wilson was instrumental in creating one of the first cardiovascular risk assessment clinics for children and adolescents. This clinic provided education to encourage healthy lifestyles, developed effective screening strategies and created novel interventions to improve the health and well-being of children and adolescents at risk for premature cardiovascular disease and type 2 diabetes mellitus.

Although most of his professional focus has been in the area of childhood diabetes, Dr. Wilson has expanded his role in the related areas of childhood obesity, insulin resistance and dyslipidemia. He is board certified by the American Board of Lipidology, a Fellow of the National Lipid Association and an Associate Editor for the Journal of Clinical Lipidology. Dr. Wilson is currently a member of the board of directors of the Southwest Lipid Association and the American Board of Clinical Lipidology

Recognizing that current approaches have proven inadequate to identify and effectively address the growing concern of premature cardiovascular disease, Dr. Wilson has been working with local, regional and national experts to create a better clinical care model that will provide enhanced health care, assessment, research and education for children and adolescents with genetic and acquired forms of dyslipidemia.

In 2009 Dr. Wilson was recruited to Phoenix Children’s Hospital. Working with a host of primary care providers, community leaders and the academic community, Dr. Wilson was able to create a unique Cardiovascular Risk Assessment, Research and Education program (C.A.R.E.) serving as the program’s director from 2009 – 2011. While in Arizona, he served as a member of Arizona’s American Academy of Pediatrics (AAP) subcommittee for childhood obesity and was selected by the National American Academy of Pediatrics to serve on a task force to evaluate the feasibility of a national obesity registry. In 2011, Dr. Wilson joined Cook Children’s Medical Center in Fort Worth, TX, where he currently serves as the Endowed Chair, Cardiovascular Health and Risk Prevention Program.


Locations:

1500 Cooper St.
Fort Worth, TX 76104
682-885-7960
Driving directions

Publications:

Publications:

Cobb, A.B, Wilson, D.P. and Abide, J.M. Use of Drugs Under the Mississippi Medicaid Program. J. of MS State Med Assoc., Vol. 13, No. 3, pp. 81-85, March1972.

Ledbetter, D.H., Ricardi, V.M., Au, W.W., Wilson, D.P. and Holmquist. Ring Chromosome 15: Phenotype, Ag-NOR Analysis, Secondary Aneuploidy, and Associated Chromosome Instability. Cytogenet. Cell. Genet. 27:11-122, 1980.

Wilson, D.P. and Endres, R.K. CSII: An Aid to Patient Selection and Training. Diabetes Care 4 (6):659-660, 1981.

Keenan, B.S., Holcombe, J.H., Wilson, D.P., Kirkland, R.T., Potts, E. and Clayton, G.W. Plasma Renin Activity and the Response to Sodium Depletion in Salt-losing Congenital Adrenal Hyperplasia. Pediatr Res 16:118-122, 1982.

Mallette, L.E., Wilson, D.P. and Kirkland, J.L. Evaluation of Hypocalcemia with a Highly Sensitive, Homologous Radioimmunoassay for Mid-region of Parathyroid Hormone. Ped. 71(1):64-69, 1983.

Wilson, D.P. and Endres, R.K. Continuous Subcutaneous Insulin Infusion (CSII). J. OK State Medical Association, 78(7):211-214, 1985.

Wilson, D.P., Carpenter, N.J. and Holcombe, J.M. Turner Syndrome: Clinical Investigation and Review. J. OK State Medical Association, 78(2):37-42, 1985.

Wilson, D.P., Fesmire, J.D., Endres, R.K. and Blackett, P.R. Increased Levels of HDL-Cholesterol and Apolipoprotein A-I after Intensified Insulin Therapy for Diabetes. Southern Medical Journal, 78(6):636-638, 1985.

Wilson, D.P., Rosenkoetter, G., and Endres, R.K. Self-monitoring of Blood Glucose. J OK State Med Assoc., 78(1):3-7, Jan 1985.

Berkovitz, G.D., Wilson, D.P., Carpenter, N.J., Brown, T.R. and Migeon, C.J. Gonadal Function in Men with the Martin-Bell (Fragile-X) Syndrome. Am. J. Med. Genet, 23(1-2):227-239, Jan 1986.

Wilson, D.P. and Coldwell, J.G. Newborn Hypothyroid Screening – The Private Sector. Am. J. Dis. Child. 139:662-663, 1985. Republished in JAMA-Southeast Asia, Supp. 1:39-40, 1986.

Wilson, D.P. and Endres, R.K. Compliance with Blood Glucose Monitoring in Children with Type I Diabetes Mellitus. J. Pediatr. 108(6):1022-1024, Jun 1986.

Wilson, D.P. and Schoenfeld, D. Microcomputer Assisted Growth Assessment. Comput in Biol Med, 16(4): 281-300, Jan 1986.

Carpenter, N.J., Mayes, J.S., and Wilson, D.P. Partial Deletion 21: Case Report with Biochemical Studies and Review. J. Med. Genet, 24(11):706-709, Nov 1987.

Malik, M. and Wilson, D.P. Umbilical Artery Catheterization: A potential Cause of Refractory Hypoglycemia. Clin Pediatr, 26(4):181-182, Apr 1987.

Stratton, R., Wilson, D.P., Endres, R.K. and Goldstein, D. Improved Glycemic Control after Supervised 8-Week Exercise Program in Insulin-Dependent Diabetic Adolescents. Diabetes Care, 10(5):589-593, Sept 1987.

Wilson, D.P. and Horowitz, J.L. Exercise-induced Changes in Growth Hormone and Somatomedin-C. Am. J. Med. Sci. 293(4):216-217, 1987.

Wilson, D.P., Horowitz, J.L., Stratton, R. and Endres, R.K. Glycosylation…An Aid in Assessing Diabetic Control. J. OK State Medical Association, 80(2):73-75, 1987.

Govaerts, K. and Wilson, D.P. On Your Own. Diabetes Forecast 41(5):69-72, 1988.

Stratton, R., Wilson, D.P. and Endres, R.K. The Acute Glycemic Effects of Exercise in Adolescents with Insulin-Dependent Diabetes Mellitus. The Physician and Sports Medicine 16(3):150-157, 1988, Diabetes Spectrum 1(4):233-234, 1988.

Wilson, D.P. Sports Participation of Children with Diabetes Mellitus. Practical Reviews in Pediatrics (audio) Vol 11(9), Dec. 1988.

Wilson, D.P. and Stratton, R. Ready, Set, Go for School Sports. Diabetes Forecast 41(8):77-78, 1988.

Wilson, D.P., Carpenter, N.J. and Berkovitz, F. Thyroid Function in Men with Fragile-X Linked Mental Retardation. Am. J. of Med. Genet 31(4):733-734, Dec 1988.

Schaefer, F.V., Swartz-Boyd, J. and Wilson, D.P. Growth Hormone: Past, Present and Future. J. Okla State Med. Assoc. 82(4):159-164, Apr 1989.

Stromquist, C., Berkel, A.I., Wilson, D.P., Gastorf, J. W. and Nierenberg, J. Serum Immunoglobulin and IgG Subclass Levels in Children and Adolescents with Insulin-Dependent Diabetes Mellitus. Acta Paediatr Scand 78(40: 639-40, Jul 1989.

Wilson, D.P., Jelley, D., Stratton, R. and Coldwell, J.G. Nephropathic Cystinosis: Improved Linear Growth after Treatment with Recombinant Human Growth Hormone. J of Pediatr 115(5, pt 1l):758-761, Nov 1989.

Zekauskas, S., Boggs, M.B. and Wilson, D.P. Human Growth Hormone and Creutzfeld – Jakob Disease. J Okla State Med Assoc Vol 83(9), 447-448. Sept 1990.

Schaefer, G.B., Greger, N.G., Fesmire, J.D., Blackett, P.R., Wilson, D.P. and Frindik, J.P. Lipids and Apolipoproteins in Growth Hormone Deficient Children during Treatment. Metabolism 43(12):1457-461, December 1994.

Blackett, P.R., Altmiller, D.H., Jelley, D. and Wilson, D.P. FH Tulsa –1 and –2: Two Unique Alleles for Familial Hypercholesterolemia Presenting in an affected Two Year Old African American Male. Am J Med Genet 59(3): 300-3, Nov 1995

Sherman, L., Wilson, D.P. How Short is Too Short? Compr Ther. Vol 21 (10): 610-5., Oct 1995.

Hardin DS, Stratton R, Kramer JC, Reyes del la Rocha S, Govaerts K, Wilson DP: “Growth Hormone Improves Weight Velocity and Height Velocity in Pre-pubertal Children with Cystic Fibrosis.” Horm Metab Res 30(10):636-641, Oct 1998.

Wilson, D.P., Beeram, M., Hypothyroxinemia of prematurity: rite of passage or therapeutic necessity? Thyroid Med 96(11): 60-3. Nov 2000.

Drummond-Borg M, Aldis B, Johnson D, Wilson DP. Newborn screening for congenital hypothyroidism: the Texas experience. Tex Med. 2003 Sep; 99(9):50-2. PMID: 14650804

Wilson, D.P. and McNeal, C.J. Hyperlipidemia, Southern Medical Association, 2004.

Pohl JF, Anding j, Wong W, Grimes R, Varni JW, Olvera N, Bush J, Butte N, O’Rear J, Rajab MH, Watts M, Sun KH, Booth T, Kjar D, Burwinkle T, Wilson D., Klish W. Pediatric Obesity in Texas: Does the Texas Public School Nutrition Policy Affect Child Nutrition? Texas Medicine, 102. 2006.

Pohl JF, Stephen M, Wilson DP. Pediatric obesity: impact and surgical management. South Med J. 2006 Aug; 99(8):833-44; quiz 845-6. PMID: 16929878

Santiago JM, Hutchinson L, Wilson DP. Visual vignette. Endocr Pract. 2007 Jan-Feb; 13(1):92. PMID: 17360311

DeSalvo D, Pohl JF, Wilson DP, Bryant W, Easley D, Greene J, Santiago J. Cholestasis secondary to panhypopituitarism in an infant. J Natl Med Assoc. 2008 Mar; 100(3):342-4. PMID: 18390029

McNeal C, Wilson DP. Metabolic syndrome and dyslipidemia in youth. J Clin Lipidol. 2008 Jun; 2(3):147-55. doi: 10.1016/j.jacl.2008.04.005. Epub 2008 Apr 12. PMID: 21291733

McNeal C, Wilson DP. Overview: Pediatric lipid disorders. J Clin Lipidol. 2008 Jun; 2(3):117. doi: 10.1016/j.jacl.2008.02.007. Epub 2008 Mar 4. PMID: 21291729

Stephen MD, Bryant WP, Wilson DP. Self-assessment of sexual maturation in children and adolescents with diabetes mellitus. Endocr Pract. 2008 Oct; 14(7):840-5. PMID: 18996811

Varni JW, Limbers CA, Burwinkle TM, Bryant WP, Wilson DP. The ePedsQL in type 1 and type 2 diabetes: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Internet administration. Diabetes Care. 2008 Apr; 31(4):672-7. doi: 10.2337/dc07-2021. Epub 2008 Jan 9. PMID: 18184893

Varni JW, Limbers CA, Bryant WP, Wilson DP. The PedsQL Multidimensional Fatigue Scale in type 1 diabetes: feasibility, reliability, and validity. Pediatr Diabetes. 2009 Aug; 10(5):321-8. doi: 10.1111/j.1399-5448.2008.00482.x. Epub 2008 Nov 20. PMID: 19067887

Brown WV, Wilson DP, Freemark M, Kwiterovich PO. The use of lipid-lowering drugs in children. J Clin Lipidol. 2010 Nov-Dec;4(6):449-61. doi: 10.1016/j.jacl.2010.10.003. Epub 2010 Oct 13. PMID: 21122691

Catherine J. McNeal, Tala Dajani, Don Wilson, Andrea E. Cassidy-Bushrow, Justin B. Dickerson, Marcia Ory. Hypercholesterolemia in Youth: Opportunities and Obstacles to Prevent Premature Atherosclerotic Cardiovascular Disease. Curr Atheroscler Rep (2010) 12:20–28.

James W Varni, Christine A Limber, William P Bryant and Don P Wilson. The PedsQLTM Multidimensional Fatigue Scale in Pediatric Obesity: Feasibility, reliability and validity. International Journal of Pediatric Obesity. 2010; 5: 34-42.

Catherine J McNeal, Lisa Underland, Don P Wilson, Piers R Blackett. Pediatric Lipid Screening. Clin Lipidology. 2013; 8(4):425-436.

Wilson DP, Gidding SS. Learning more about dyslipidemia in childhood. J Pediatr. 2014 Mar; 164(3):442-4. doi: 10.1016/j.jpeds.2013.11.030. Epub 2013 Dec 24. No abstract available. PMID: 24373576

Ahmad Z, Wilson DP. Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1. J Clin Lipidol. 2014 Nov-Dec; 8(6):635-9. doi: 10.1016/j.jacl.2014.08.010. Epub 2014 Sep 9. PMID: 25499947

Ahmad, Z., & Wilson, D. P. (2014). Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1. Journal of Clinical Lipidology, 8(6), 635-639. doi:S1933-2874(14)00314-6 [pii]

Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., Wilson, D. P., & Brown, W. V. (2014). National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 - executive summary. Journal of Clinical Lipidology, 8(5), 473-488. doi:10.1016/j.jacl.2014.07.007 [doi]

McNeal, C. J., Zachariah, J. P., Gregory, S., Cassidy-Bushrow, A. E., Wilson, D. P., Tom, J. O., VanWormer, J. J., Wright, E. A., & Copeland, L. A. (2014). Identifying and reducing barriers to improve lipid screening in youth. Current Cardiovascular Risk Reports, 8(8), 1-7.

Wilson, D. P., McNeal, C. J., Willcutts, M., Le, N., Pourfarzib, R., & Winegar, D. (2014). Identifying insulin resistant children utilizing lipoprotein-based measurements. Journal of Clinical Lipidology, 8(3), 300-301.

Alejandro De La Torre, MD and Don P. Wilson, MD, FNLA, Piers R Blackett MD, and Catherine J McNeal, M.D., PhD. Cardiovascular Disease Risk in Youth with Metabolic Syndrome. Lipid Spin. Fall, 2015.

Blackett PR, Wilson DP., McNeal CJ. Secondary hypertriglyceridemia in children and adolescents. J Clin Lipidol. 2015 Sep-Oct; 9(5 Suppl):S29-40. doi: 10.1016/j.jacl.2015.04.006. Epub 2015 May 1. PMID: 26343210

Wilson DP., Gidding SS. Atherosclerosis: Is a cure in sight? J Clin Lipidol. 2015 Sep-Oct; 9(5 Suppl):S1-4. doi: 10.1016/j.jacl.2015.06.010. Epub 2015 Jun 18. PMID: 26343206

Wilson DP., McNeal C, Blackett P. Pediatric dyslipidemia: recommendations for clinical management. South Med J. 2015 Jan; 108(1):7-14. doi: 10.14423/SMJ.0000000000000219. PMID: 25580750

Wilson, D. P., Blackett, P. R., & McNeal, C. J. Dyslipidemia, cardiovascular disease, and youth with diabetes. Lipid Spin. Sprig 2015.

Alejandro De La Torre, MD and Don P. Wilson, MD, FNLA. Cardiovascular Disease Risk in Youth with Metabolic Syndrome. Lipid Spin. Fall, 2015.

Blackett PR, Wilson DP., McNeal CJ. Secondary hypertriglyceridemia in children and adolescents. J Clin Lipidol. 2015 Sep-Oct; 9(5 Suppl):S29-40. doi: 10.1016/j.jacl.2015.04.006. Epub 2015 May 1. PMID: 26343210

Brautbar A, Leary E, Rasmussen K, Wilson DP., Steiner RD, Virani S. Genetics of familial hypercholesterolemia. Curr Atheroscler Rep. 2015 Apr; 17(4):491. doi: 10.1007/s11883-015-0491-z. PMID: 25712136

Harold E. Bays, MD, FTOS, FACC, FACE, FNLA*, Peter H. Jones, MD, FACP, FNLA, Carl Orringer, MD, FNLA, et. al. National Lipid Association Annual Summary of Clinical Lipidology 2015. Volume 8, Issue 6, Supplement, November–December 2014, Pages S1–S36

Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA, Wilson DP., Brown WV. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report. J Clin Lipidol. 2015 Mar-Apr;9(2):129-69. doi: 10.1016/j.jacl.2015.02.003. Epub 2015 Apr 7. PMID: 25911072

Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA, Wilson DP., Brown WV. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report. J Clin Lipidol. 2015 Mar-Apr; 9(2):129-69. doi: 10.1016/j.jacl.2015.02.003. Epub 2015 Apr 7. PMID: 25911072

McNeal CJ, Toth PP, Wilson DP.. Hot Topics in Primary Care: Familial Hypercholesterolemia in Youth. J Fam Pract. 2015 Dec; 64(12 Suppl):S22-30. PMID: 26845009

Shah AS, Wilson DP.. Primary hypertriglyceridemia in children and adolescents. J Clin Lipidol. 2015 Sep-Oct; 9(5 Suppl):S20-8. doi: 10.1016/j.jacl.2015.04.004. Epub 2015 Apr 25. PMID: 26343209

Terry A. Jacobson, Kevin C. Maki, Carl Orringer, Peter Jones, Penny Kris-Etherton, Geeta Sikand, Ralph La Forge, Stephen Daniels, Don Wilson, Pamela Morris, [...], Michael A. Horberg, Christopher T. Longenecker, Merle Myerson, E. Turner Overton, Jonathon S. Coblyn, Jeffrey Curtis, Jorge Plutzky, Daniel Solomon, Harold Bays, W. Virgil Brown. National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2. Journal of Clinical Lipidology 09/2015; DOI:10.1016/j.jacl.2015.09.002

Wild, R., Weedin, E., & Wilson, D. P.(2015). Dyslipidemia in pregnancy. Cardiology Clinics, 33(2), 209-215.

Wilson DP, Davis S, Matches S, Shah D, Leung-Pineda V, Mou M, Hamilton L, McNeal CJ, Bowman WP. Universal cholesterol screening of children in community-based ambulatory pediatric clinics. J Clin Lipidol. 2015 Sep-Oct; 9(5 Suppl):S88-92. doi: 10.1016/j.jacl.2015.05.006. Epub 2015 May 27. PMID: 26343216

Wilson DP, McNeal C, Blackett P. Pediatric dyslipidemia: recommendations for clinical management. South Med J. 2015 Jan; 108(1):7-14. doi: 10.14423/SMJ.0000000000000219. PMID: 25580750

Harold E. Bays, MD, FTOS, FACC, FACE, FNLA*, Peter H. Jones, MD, FACP, FNLA, Carl Orringer, MD, FNLA, et. al. National Lipid Association Annual Summary of Clinical Lipidology 2016. Volume 10, Issue 1, Supplement, January–February 2016, Pages S1–S43.

 

Abstracts:

Mallette, L.E., Wilson, D.P. and Kirkland, J. Measurement of Human Parathyroid Hormone (44-53) Immunoreactivity with Humologous Antiserum. Endocrine Society, 1980.

Holmes, L., Cheek, J. and Wilson, D.P. Evaluation of a Commercial Glucose Oxidase Reagent Strip. Diabetes 31, Supp. 2:401, 1982.

Wilson, D.P., Endres, R.K., Fesmire, J.D. and Blackett, P.R. Increases in HDL Cholesterol, (HDLc) and Apolipoprotein A-1(apo A-1) after Increasing the Frequency of Insulin Administration and the Total Daily Dose. Diabetes 31, 2:594, 1982.

Wilson, D.P., Horowitz, J. and Endres, R.K. Evaluation of Carbohydrate Intolerance in Patients with Gonadal Dysgenesis. Clin Res 30(5):898A, 1982.

Schoenefeld, D. and Wilson, D.P. Microcomputer Assisted Growth Evaluation. Endocrine Society, 1983.

Wilson, D.P. and Endres, R.K. Compliance with Home Glucose Monitoring in Children with Diabetes Mellitus. Southern Society for Pediatric Research. 1983

Wilson, D.P., Malik, S. and Horowitz, J. Somatomedin-C Response to Metered Exercise Tolerance. Southern Society for Pediatric Research. 1983

Wilson, D.P. and Coldwell, J.G. Tulsa Collaborative Newborn Screening. Clinical Research 31(5), 1983.

Wilson, D.P., Brown, J. and Say, B. Genital Hypoplasia in Males with the CHARGE Association. Human Genetics, 37(4):A82, 1985.

Stratton, R., Wilson, D.P. and Endres, R.K. Changes in Blood Glucose with Aerobic and Recreational Exercise in Type I Diabetes Mellitus. Clinical Research, December, 34(1):252A, 1986.

Stratton, R., Wilson, D.P., Endres, R.K., and Goldstein, D. Glycosylated Serum Albumin: An Index of Exercise Induced Improvement in Diabetic Control. Medicine and Science in Sports and Exercise. 18(2) Supplement: S70, 1986.

Stromquist, C., Berkel, A.I., Wilson, D.P. and Gastorf, J.W. IgG Subclasses in Children and Adolescents with Type I Diabetes. Pediatric Research, 1987.

Stratton, R., Wilson, D.P., Endres, R.K. and Horowitz, J. Exercise-Induced Reduction in Glycosylated Serum Albumin with no Charge in Total Plasma Albumin in Adolescents with Insulin-Dependent Diabetes Mellitus. Medicine and Science in Sports and Exercise, 19(2):5-74, 1987.

Schaefer, F.S., Wilson, D.P. and Swartz, J.C. Diagnosis of Isolated Growth Hormone Deficiency Type 1A (IGHD 1A) with Recombinant DNA Probe to the Growth Hormone Gene. Am. J. of Human Genetics, 41(3):A81, supp., 1987.

Stratton, R., Wilson, D., Endres, R.K. and Lantz, G. Use of Vagal Tone Monitoring in the Assessment of Diabetic Autonomic Neuropathy. OU-Tulsa Medical College Research Day, 1987.

Govaerts, K. and Wilson, D.P. Application of Behavioral Techniques in the Management of IDDM. OU-Tulsa Medical College Research Day, 1987.

Chetty, D., Horowitz, J., Holocombe, J. and Wilson, D.P. Low Dose Estrogen Therapy in Turner Syndrome. OU-Tulsa Medical College Research Day, 1987.

Berkel, I., Nierenberg, J. and Wilson, D.P. DiGeorge Syndrome: Spontaneous Improvement in Cell Mediated Immunity. OU-Tulsa Medical College Research Day, 1987.

Stratton, R., Wilson, D.P. and Endres, R.K. Early Assessment of Diabetic Autonomic Neuropathy in Children and Adolescents. OU-Tulsa Medical College Research Day, 1988.

Govaerts, K., Stratton, R., Endres, R.K. and Wilson, D.P. Changes in Glycohemoglobin Following Initial Treatment of Insulin-Dependent Mellitus. OU-Tulsa Medical College Research Day, 1988.

Horowitz, J., Stratton, R. and Wilson, D.P. Correlation Between 12-hour and 24-hour Studies for Growth Hormone Release. OU-Tulsa Medical College Research Day, 1988.

Jelley, D., Coldwell, J.G. and Wilson, D.P. Nephropathic Cystinosis: Response to Biosynthetic Growth Hormone Therapy. OU-Tulsa Medical College Research Day, 1988.

Christensen, J., Stratton, R., Wilson, D.P. and Endres, R.K. Diet Prescriptions and Adjustments for Summer Camp in Diabetic Children and Adolescents. OU-Tulsa Medical College Research Day, 1988.

Zekauskas, S. and Wilson, D.P. Pseudofamilial Growth Hormone Deficiency. OU-Tulsa Medical College Research Day, 1988.

Leach, J., Koljack, K. and Wilson, D.P. Congenital Absence of the Penis. OU-Tulsa Medical College Research Day, 1989.

Cyrus, K., Ramsey, S., Stratton, R. and Wilson, D.P. Body Mass Index in Adolescent Females with Insulin-Dependent Diabetes Mellitus (IDDM). OU-Tulsa Medical College Research Day, 1989.

Horowitz, J., Foster, J., Stratton, R., and Wilson, D.P. Glycosylated Hemoglobin Trends in Children and Adolescents with Insulin Dependent Diabetes Mellitus (IDDM). OU-Tulsa Medical College Research Day, 1989.

Foster, J., Stratton, R., Wilson, D.P., Schaefer, G.B. and Kemp, S.F. Predicting Response to Growth Hormone (GH) Treatment. OU-Tulsa Medical College Research Day, 1989.

Bryant, W., Wilson, D.P., Hubner, D. and Stratton, R. Accuracy and Precision of Newer Home Blood Glucose Monitors. OU-Tulsa Medical College Research Day, 1989.

Govaerts, K. and Wilson, D.P. Neuropsychological Functioning in Children with Nephropathic Cystinosis. OU-Tulsa Medical College Research Day, 1989.

Stratton, R., Wilson, D.P. and Endres, R.K. Changes in Autonomic Function Associated with Glycosylated Hemoglobin Changes in Diabetic Adolescents. OU-Tulsa Medical College Research Day, 1989.

Wilson, D.P. and Coldwell, J.G. Vitamin-D Dependent Rickets, Hyperthyroidism, and Infantile Hypophophantasia (IH). OU-Tulsa Medical College Research Day, 1989.

Zekauskas, S. and Wilson, D.P. Growth Screening for Short Stature. OU-Tulsa Medical College Research Day, 1989.

Kukas, L., Cyrus, K. and Wilson, D.P. Patients treated with Protropin – Comparing Data from Children’s Medical Center, Tulsa, Oklahoma with National Cooperative Growth Study. OU-Tulsa Medical College Research Day, 1989.

Endres, R.K., Stratton, R., Horowitz, J. and Wilson, D.P. Lipid Profile in Children and Adolescents with IDDM. OU-Tulsa Medical College Research Day, 1989.

Jelley, D., Wilson, D.P. and Breman, R. PTU Toxicity. OU-Tulsa Medical College Research Day, 1989.

Foster, J., Boyd, C., Duvall, D. and Wilson, D.P. Response to Biosynthetic Growth Hormone in Naïve “GH Deficient” vs. “Idiopathic” Short Stature Children. OU-Tulsa Medical College Research Day, 1990.

Wilson, D.P., Boyd, C., Kramer, J., Reyes, J. and Horowitz, J. Use of Recombinant Human Growth Hormone (rhGH) in Children and Adolescents with Cystic Fibrosis. OU-Tulsa Medical College Research Day, 1990.

Kasprisin, D., Wilson, D.P., O’Quinn, M. and Cooper, C. Plasmapheresis in Homozygous Familial Hypercholesterolemia. OU-Tulsa Medical College Research Day, 1990.

Swartz-Boyd, J., Wilson, D.P. and Schaefer, F.V. Incidence of Isolated Growth Hormone Deficiency Type 1A in the Midwest Population. Am. Society of Human Genetics, 1988.

Schaefer, F.V., Swartz-Boyd, J.C., Wilson, D.P. and Roe, B. Sequence Variations in the Regulatory Sequences of Growth Hormone Releasing Factor (GHRF). Am. Society of Human Genetics.

Govaerts, K., Stratton, R. and Wilson, D.P. Changes in Glycohemoglobin Following Initial Treatment of Insulin-Dependent Diabetes Mellitus. Proceedings of the Southern Medical Association, p. 135, 1988.

Horowitz, J., Stratton, R. and Wilson, D.P. Correlation Between 12-hour and 24-hours Studies for Growth Hormone Release. Proceedings of the Southern Medical Association, p. 134, 1988.

Stratton, R., Wilson, D.P. and Endres, R.K. Heart Rate Variability Scores in Children and Adolescents with Insulin-Dependent Diabetes Mellitus. Proceedings of the Southern Medical Association, p. 134, 1988.

Stratton, R., Wilson, D.P. and Endres, R.K. Early Assessment of Diabetic Autonomic Neuropathy in Children and Adolescents. Diabetes 37 (supp 1): 237A, 1988.

Jelley, D., Wilson, D.P., Stratton, R. and Coldwell, J.G. Nephropathic Cystinosis: Reponse to Biosynthetic Growth Hormone (rhGH). Clinical Research 37(1), 1989.

Stratton, R., Govaerts, K. and Wilson, D.P. Apolipoprotein Changes with a Normal Exercise Program in Insulin-Dependent Adolescents. Diabetes 138, Supp. 22:213A, 1989.

Wilson, D.P., Stratton, R. and Endres, R.K. Changes in Autonomic Function Associated with HgbA1 Changes in Adolescents with IDDM. Diabetes 38, Supp. 2:25A, 1989.

Schaefer, G.B., Blackett, P.R., Frindik, J.P. and Wilson, D.P. Short Term and Intermediate Effects of Growth Hormone Upon Apolipoprotein Status. NCGS Symposium IV, 1989.

Schaefer, G.B., Ransom, G., Garnica, A., Wilson, D.P. and Seely, J. Increased Incidence of 21-Hydroxylase Deficiency among the American Indians of Oklahoma.

Schaefer, G.B., Blackett, P.R., Frindik, J.P. and Wilson, D.P. Short Term and Intermediate Effects of Growth Hormone Upon Apo-lipo Protein Status. NCGS Symposium IV, 1989.

Wilson, D.P., Stratton, R., Boyd, C., Kramer, J., Reyes, J., and Horowitz, J. Use of Recombinant Human Growth Hormone (rhGH) in Children with Cystic Fibrosis. National Cooperative Growth Study – Symposium V. (Poster Presentation) Ft. Lauderdale. Nov 10-13, 1990.

Wilson, D.P., Schaefer, B., Kemp, S., and Stratton, R. Response to Biosynthetic Growth Hormone Therapy in “GH-Deficient” vs. “Non-Deficient” Children. (Oral Presentation) Southern Society for Pediatric Research. New Orleans, Louisiana. November 19, 1990.

Schaefer, G.B., Blackett, P.R., Frindik, J.P. and Wilson, D.P. Short Term and Intermediate Effects of Growth Hormone Upon Alipoprotein Status. (Oral Presentation) Society for Pediatric Research. New Orleans, Louisiana. November 18, 1990.

Sullivan, S., R.N., B.S.N.; Gonzalez, M., R.N., B.S.N.; and Wilson, D., M.D. School Based Growth Screening – The CCISD Project. 1993 National Cooperative Growth Study Meeting (NCGS).

Wilson, D. Kids and Cholesterol. 1994 Texas Public Health Association Meeting. Corpus Christi, Texas. March 1, 1994.

Sherman, L., Wilson, D.P., Zamir, A., Sullivan, S. and Timperlake, R. Spinal Cord Injury – An Unusual Complication in a Patient with Cushing’s Disease (ABS). Eight Annual Investigators Meeting. NCGS. University of South Florida. October 27-30, 1994.

Wilson D, Lukefahr J, Swarup J, and Zapalac P. Accuracy of portable blood glucose monitoring devices. Costal Bend Medicine. 1995

Berenguer, A., Burke, M., Summers, M. and Wilson, D.P. Diencephalic Syndrome: Are Humral Factors Responsible for Emaciation? Pediatric Endocrine Society of Texas, Oklahoma, and Louisiana. Dallas, Texas. April 19, 1996.

McNeal CJ, Houck PD, Mixon T, Wilson DP. The Effects of Lipid Lowering Therapy on Endothelial Function in Children with Hypercholesterolemia. 2003.

McNeal CJ, Wilson DP, Meininger CJ, MacFarlane, Farwig ZN. The Effects of Simvastatin on Endothelial Function in Children with Hypercholesterolemia. 2003.

Adrenoleukodystrophy. Cora Hizon, M.D., Saunder M. Bernes, M.D., Don P. Wilson, M.D. University of Arizona College of Medicine. 2nd Place Award-Research Excellence Day.

Hemoglobin A1c and glucose response during OGTT among healthy, prediabetic, and diabetes. Shaibi, Hackett, Monge, Miller, Wilson, and Mandarino. Abstract--Obesity Society Annual Meeting.

Awareness of cardiovascular risk factors by pediatric health care providers. Sonali Belapukar, M.D. and Don P. Wilson, M.D. European Society of Pediatric Endocrinology, 49th Annual Meeting, September 2010, Prague, Czech Republic.

Osteopetrorickets. Sonali Belapukar, M.D. and Don P. Wilson, M.D. University of Arizona College of Medicine. 1st Place Award - Research Excellence Day.

An academic-community-clinic partnership to reduce weight in Hispanic youth: FIT for Health. Heather Kitzman-Ulrich, PhD and Don P. Wilson, M.D. TPHA 2014 Annual Educational Conference.

Mou, M., Wilson, D.P., Davis, S., Matches, S., Shah, D., Leung-Pineda, V., Suzuki, S., McNeal, C. J., & Bowman, W. P. (2015). Universal cholesterol screening of all 9- to 11-year-old children in community-based ambulatory pediatric clinics. Journal of Clinical Lipdology, 9(3), 443.

Diabetes mellitus in a 12-year-old Vietnamese American female with congenital hyperinsulinism (ABCC8). Jennigale Webb, MS-4, Paul Thornton, M.D. and Don P Wilson, M.D., FNLA. Presented at the Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas (PESTOLA) annual scientific meeting. January 24-25, 2015. Dallas Texas.

A 3-Year-Old with Severe Hypercholesterolemia. Amol Patel, MS-2, Alejandro de la Torre, M.D., Ariel Brautbar, M.D. and Don P. Wilson, M.D., FNLA. Presented at the Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas (PESTOLA) annual scientific meeting. January 24-25, 2015. Dallas Texas.

Iodine: A Catalyst for Transient Congenital Hypothyroidism. Nayana Baby, MS-2, John Dallas, M.D. and Don P. Wilson, M.D., FNLA. Presented at the Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas (PESTOLA) annual scientific meeting. January 24-25, 2015. Dallas Texas.

Cost and LOS Comparison for Treatment of Diabetic Ketoacidosis (DKA) in Individuals < 18 Years of Age. Susan Hsieh, M.D., Paul Thornton, M.D., Shane Fernando, M.D. and Don P. Wilson, M.D., FNLA. Presented at the Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas (PESTOLA) annual scientific meeting. January 24-25, 2015. Dallas Texas. Presented at the Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas (PESTOLA) annual scientific meeting. January 24-25, 2015. Dallas Texas.

Universal Screening of all 9-11 yr old Children for Hypercholesterolemia in Community Based Ambulatory Pediatric Clinics. Margaret Mou, MS-4, Don P. Wilson M.D.,FNLA, Sharon Davis, D.O., Sarah Matches, D.O. , Deep Shah, M.D., Van Leung-Pineda, PhD, Sumihiro Suzuki, PhD, Catherine J. McNeil, M.D., PhD ,and Paul Bowman, M.D. Presented at the Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas (PESTOLA) annual scientific meeting. January 24-25, 2015. Dallas Texas.

Primary Pigmented Nodular Adrenal Disease – An Usual Cause of Cushing’s Syndrome. Sameer Prakash, MS-2, Nicole Maxie, MS-3, Melanie Russ, RN, James Friedman, M.D., James P Miller, M.D. and Don P. Wilson, M.D., FNLA. Presented at the Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas (PESTOLA) annual scientific meeting. January 24-25, 2015. Dallas Texas.

Pediatric Cardiovascular Screening. Margaret Mou, MS-4 and Don Wilson, M.D., FNLA. Presented at the Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas (PESTOLA) annual scientific meeting. January 24-25, 2015. Dallas Texas.

Readmission rates for DKA. Peter Deleeuw, MS-2, Paul Thornton, M.D., Susan Hsieh, M.D., Jose Gonzalez, M.D. and Don Wilson, M.D., FNLA. Presented at the Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas (PESTOLA) annual scientific meeting. January 24-25, 2015. Dallas Texas.

Severe insulin resistance in Ahlstrom’s syndrome. Knoelle Park, MS-2, Michael Willcutts, M.D., and Don Wilson, M.D. Presented at the Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas (PESTOLA) annual scientific meeting. January 24-25, 2015. Dallas Texas.

Optimizing Glycemic Control in Hospitalized Children with Diabetes. Jason Evans, Pharm.D., Lorrainea Williams, Pharm.D., Kelli Goree, R.N., Pavani Akundi, Paul Thornton, M.D. and Don P. Wilson, M.D. 2015 ASHP - Medication Safety Collaborative meeting. June 9th, 2015. Denver, Colorado.

Diabetes mellitus in a 12-year-old Vietnamese American female with congenital hyperinsulinism (ABCC8). Jennigale Webb, MS-4, Paul Thornton, M.D. and Don P Wilson, M.D., FNLA. Research Appreciation Day. University of North Texas Health Sciences Center. April, 17th, 2015. Fort Worth Texas.

A 3-Year-Old with Severe Hypercholesterolemia. Amol Patel, MS-2, Alejandro de la Torre, M.D., Ariel Brautbar, M.D. and Don P. Wilson, M.D., FNLA. Research Appreciation Day. University of North Texas Health Sciences Center. April, 17th, 2015. Fort Worth Texas.

Iodine: A Catalyst for Transient Congenital Hypothyroidism. Nayana Baby, MS-2, John Dallas, M.D. and Don P. Wilson, M.D., FNLA. Research Appreciation Day. University of North Texas Health Sciences Center. April, 17th, 2015. Fort Worth Texas. Research Appreciation Day. University of North Texas Health Sciences Center. April, 17th, 2015. Fort Worth Texas.

Universal Screening of all 9-11 yr old Children for Hypercholesterolemia in Community Based Ambulatory Pediatric Clinics. Margaret Mou, MS-4, Don P. Wilson M.D., FNLA, Sharon Davis, D.O., Sarah Matches, D.O. , Deep Shah, M.D., Van Leung-Pineda, PhD, Sumihiro Suzuki, PhD, Catherine J. McNeil, M.D., PhD ,and Paul Bowman, M.D. Research Appreciation Day. University of North Texas Health Sciences Center. April, 17th, 2015. Fort Worth Texas.

Primary Pigmented Nodular Adrenal Disease – An Usual Cause of Cushing’s Syndrome. Sameer Prakash, MS-2, Nicole Maxie, MS-3, Melanie Russ, RN, James Friedman, M.D., James P Miller, M.D. and Don P. Wilson, M.D., FNLA. Research Appreciation Day. University of North Texas Health Sciences Center. April, 17th, 2015. Fort Worth Texas.

Pediatric Cardiovascular Screening. Margaret Mou, MS-4 and Don Wilson, M.D., FNLA.

Readmission rates for DKA. Peter Deleeuw, MS-2, Paul Thornton, M.D., Susan Hsieh, M.D., Jose Gonzalez, M.D. and Don Wilson, M.D., FNLA. Research Appreciation Day. University of North Texas Health Sciences Center. April, 17th, 2015. Fort Worth Texas.

Severe insulin resistance in Ahlstrom’s syndrome. Knoelle Park, MS-2, Michael Willcutts, M.D., and Don Wilson, M.D. Research Appreciation Day. University of North Texas Health Sciences Center. April, 17th, 2015. Fort Worth Texas.

National Lipid Association’s Annual Scientific Meeting. June 11-14, 2015. Chicago, Illinois.

A 3-Year-Old with Severe Hypercholesterolemia. Amol Patel, MS-2, Alejandro de la Torre, M.D., Ariel Brautbar, M.D. and Don P. Wilson, M.D., FNLA. The Journal of Clinical Lipidology.

Pediatric Cardiovascular Screening. Margaret Mou, MS-4 and Don Wilson, M.D., FNLA. The Journal of Clinical Lipidology. May–June, 2015Volume 9, Issue 3, Pages 443–444.

The Prevalence of Dyslipidemia and other Cardiovascular Risk Factors in Youth with Diabetes. Amelia Vinson, R.N., Don P. Wilson, M.D., FNLA, Crystal M. O’Reilly, Jose Gonzalez, M.D., Alejandro de la Torre, M.D., and Ariel Brautbar, M.D. The Journal of Clinical Lipidology. May–June, 2015Volume 9, Issue 3, Page 417.

Universal Cholesterol Screening (UCS) in youth. Margaret Mou, MS-4, Don P. Wilson, MD, FNLA, Sharon Davis, DO, Sarah Matches, DO,Deep Shah, MD,Van Leung-Pineda, PhD, Sumihiro Suzuki, PhD, Catherine J. McNeal, MD, PhD, Paul Bowman, MD, Fort Worth, TX. The Journal of Clinical Lipidology. May–June, 2015Volume 9, Issue 3, Page 443.

Pediatric Endocrine Society of Texas, Oklahoma, Louisiana and Arkansas (PESTOLA) Annual Scientific Meeting. January 22-24, 2016. Fort Worth, Texas

Hyperinsulinism Secondary to Congenital Disorder of Glycosylation Type 1b. Woongsoon Choi, MS, Paul Thornton, MD, Alice Basinger, MD, PhD, James G. Coldwell, MD, Luke Hamilton, and Don Wilson, MD, Two Siblings with Rare Lipid Disorder Complicated by Arrhythmias. Mir Ali, MS, Alejandro De La Torre, MD, Ariel Brautbar, MD, Luke Hamilton, MS, and Don Wilson, MD

Severe Salt Wasting in a 16-day-old Male. Luke Cielonko, MS, Don Wilson, MD, Luke Hamilton and Alejandro de la Torre, MD

Use of Pamidronte in Subcutaneous Fat Necrosis-Associated Hypercalcemia. E. Bowden, MPH, M. Drake, MS, J. Radack, MD, R. Hamilton, M.D., L. Hamilton, MS, S. Sharatz, M.D. and D. Wilson, M.D.

Treatment of Severe Hypercalcemia with Intravenous Bisphosphonate in Williams Syndrome. Kari Galipp, MS, Teena Thomas, MD, Luke Hamilton, MS, and Don Wilson

Mucolipidosis Type II (I-Cell disease). H. Dehbozorgi, BS, A. Brautbar, MD, L. Hamilton, MS and D. Wilson, MD

HbA1c vs FPG and 2-Hour OGTT Glucose in Identifying Dysglycemia in Obese Youth. Ngan Kim Huynh, Alejandro DeLaTorre, MD, Luke Hamilton, MS and Don Wilson, MD

Growth Hormone Treatment of 2 Siblings with Rapadilino Syndrome. Daryl McKee, MS, Susan Hsieh, MD, Margaret Drummondborg, MD, Luke Hamilton, MS, and Don Wilson, MD

Readmission Rates for Children with Diabetic Ketoacidosis (DKA). Luke Hamilton, M.S., Paul Thornton, M.D., Jose L. Gonzalez, M.D., J.D., M.S.Ed., Susan Hsieh, M.D., and Don P. Wilson, M.D.

 

 

Rocket Fuel